The FDA needs to regulate kratom as an NDI (new dietary ingredient) to avoid a patchwork of conflicting state regulations, the American Herbal Products Association argues, joining the push to keep it available to consumers. Kratom, an herbal extract used to manage opioid withdrawal, garnered unwelcome scrutiny after products containing the herb were potentially linked to a salmonella outbreak. Supporters say the FDA should stop demonizing kratom and treat it like other dietary ingredients. But is it too late? Several states have already banned kratom. If the FDA doesn’t change its position, will it remain available at all? Find out what the future may hold for this controversial product.